This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Embera NeuroTherapeutics, Inc.

Drug Names(s): EMB001, OX/MET

Description: EMB-001 is the combination use of benzodiazepine oxazepam and the cortisol synthesis inhibitor metyrapone. The compounds uniquely modulate stress-related pathways like the corticotropin-releasing factor (CRF) and the gamma-aminobutyric acid (GABA) system.

EMB-001 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug